Literature DB >> 20276993

Cyclofusional movements.

K N OGLE, V J ELLERBROCK.   

Abstract

Keywords:  EYES/movements

Mesh：

Year:  1946        PMID： 20276993     DOI： 10.1001/archopht.1946.00890210713005

Source DB:  PubMed          Journal:  Arch Ophthal


× No keyword cloud information.
  10 in total

1.  Optically induced eye torsion. I. Fusion cyclovergence.

Authors:  R A Crone; Y Everhard-Hard
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-07-04

2.  The vertical horopter is not adaptable, but it may be adaptive.

Authors:  Emily A Cooper; Johannes Burge; Martin S Banks
Journal:  J Vis       Date:  2011-03-29       Impact factor: 2.240

3.  Comments on cyclofusional eye movements.

Authors:  S Krekling
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973-10-19

4.  Heterophoria. II. Fusion and convergence.

Authors:  R A Crone
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1969

5.  Cyclovergence: the motor response to cyclodisparity.

Authors:  K Hooten; E Myers; R Worrall; L Stark
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-03-05

6.  Cyclovergence: a comparison of objective and psychophysical measurements.

Authors:  I P Howard; M Ohmi; L Sun
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Cyclofusion and stereopsis.

Authors:  A E Kertesz
Journal:  Percept Psychophys       Date:  1983-01

8.  Absence of depth processing in the large-frame rod-and-frame effect.

Authors:  S M Ebenholtz; G W Glaser
Journal:  Percept Psychophys       Date:  1982-08

9.  Human cyclovergence as a function of stimulus frequency and amplitude.

Authors:  I P Howard; J E Zacher
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

10.  Comparison of torsional amplitudes between emmetropes and myopes using after-image slides.

Authors:  Antony Arokiadass Baskaran; Tanuja Britto; Sundaresan Rajkumar; Philip A Thomas; C A Nelson Jesudasan
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.